Hostname: page-component-7b7567c8c-2n9c9 Total loading time: 0 Render date: 2026-11-14T23:45:48.005Z Has data issue: false hasContentIssue false
  • English
  • Français

Amorphous Polymer Networks Combining Three Functionalities–Shape-memory, Biodegradability, and Drug Release

Published online by Cambridge University Press:  31 January 2011

Christian Wischke,
Axel Thomas Neffe,
Susi Steuer and
Andreas Lendlein
Christian Wischke
Affiliation:
christian.wischke@gkss.de, GKSS Research Center Geesthacht GmbH, Center for Biomaterial Development, Teltow, Germany
Axel Thomas Neffe
Affiliation:
axel.neffe@gkss.de, GKSS Research Center Geesthacht GmbH, Center for Biomaterial Development, Teltow, Germany
Susi Steuer
Affiliation:
teltow@gkss.de, Intervet Innovation GmbH, Schwabenheim, Germany
Andreas Lendlein
Affiliation:
lendlein@online.de, GKSS Research Center Geesthacht GmbH, Center for Biomaterial Development, Teltow, Germany
Get access

Abstract

Shape-memory polymers are of high scientific and technological interest in the biomedical field, e.g., as matrix for self-anchoring implantable devices. In this study, two different star-shaped copolyester tetroles, semi-crystalline oligo[(-caprolactone)-co-glycolide]tetrol (oCG) and amorphous oligo[(rac-lactide)-co-glycolide]tetrol (oLG), were synthesized and subsequently crosslinked by a low molecular weight diisocyanate resulting in copolyester urethane networks (N-CG, N-LG). Both networks could be loaded with model drugs and a diffusion controlled release of the drugs was observed without any effect on the mass loss as measure of hydrolytic degradation. However, the N-CG network’s capability of shape programming was disturbed as the crystallinity of the precursors got lost in the complex three dimensional architecture after crosslinking. By contrast, amorphous N-LG network showed an excellent shape-memory capability with a switching temperature around 36 °C corresponding to their glass transition temperature. This led to triple-functional materials combining biodegradability, shape-memory, and controlled drug release.

Keywords

biomedicalbiomaterialpolymer

Information

Type
Research Article
Information
MRS Online Proceedings Library (OPL) , Volume 1190: Symposium NN – Active Polymers , 2009, 1190-NN11-34
Copyright
Copyright © Materials Research Society 2009

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Article purchase

Temporarily unavailable

References

1 Behl, M., Lendlein, A., Soft Matter 3 (2007), 58–67.10.1039/B610611KGoogle Scholar
2 Gall, K., Yakacki, C.M., Liu, Y., Shandas, R., Willett, N., Anseth, K.S., J. Biomed. Mater. Res. Part A 73A (2005) 339–348.10.1002/jbm.a.30296Google Scholar
3 Lendlein, A., Langer, R., Science 296 (2002) 1673–1676.10.1126/science.1066102Google Scholar
4 Sharp, A.A., Panchawagh, H.V., Ortega, A., Artale, R., Richardson-Burns, S., Finch, D.S., Gall, K., Mahajan, R.L., Restrepo, D., J. Neural Eng. 3 (2006) L23–L30.10.1088/1741-2560/3/4/L02Google Scholar
5 Small, W., Wilson, T.S., Buckley, P.R., Benett, W.J., Loge, J.M., Hartman, J., Maitland, D.J., IEEE Trans Biomed Eng 54 (2007) 1657–1666.10.1109/TBME.2007.892921Google Scholar
6 Weigel, Th., R, Mohr, A, Lendlein, Smart Mater. Struct. 18 (2009) 025011 (9pp).10.1088/0964-1726/18/2/025011Google Scholar
7 Mohr, R., Kratz, K., Weigel, T., Lucka-Gabor, M., Moneke, M., Lendlein, A., Proc. Natl. Acad. Sci. USA 103 (2006) 3540–3545.10.1073/pnas.0600079103Google Scholar
8 Lendlein, A., Jiang, H., Jünger, O., Langer, R., Nature 434 (2005) 879–882.10.1038/nature03496Google Scholar
9 Neffe, A.T., Hanh, D.B., Steuer, S., Lendlein, A., Polymer networks combining controlled drug release, biodegradation, and shape-memory capability, Adv. Mat. in press, DOI: 10.1002/adma.20080233310.1002/adma.200802333Google Scholar
10 Wischke, C., Neffe, A., Steuer, S., Lendlein, A.. Evaluation of a degradable shape-memory polymer network as matrix for controlled drug release. J. Controlled Release in press, doi:10.1016/j.jconrel.2009.05.027.Google Scholar